- Home
- YGMZ vs KTTA Comparison
YGMZ vs KTTA Comparison
Compare YGMZ & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YGMZ
- KTTA
- Stock Information
- Founded
- YGMZ 2002
- KTTA 2020
- Country
- YGMZ China
- KTTA United States
- Employees
- YGMZ N/A
- KTTA N/A
- Industry
- YGMZ Transportation Services
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- YGMZ Consumer Discretionary
- KTTA Health Care
- Exchange
- YGMZ Nasdaq
- KTTA Nasdaq
- Market Cap
- YGMZ 5.5M
- KTTA 5.3M
- IPO Year
- YGMZ 2020
- KTTA 2021
- Fundamental
- Price
- YGMZ $0.12
- KTTA $0.94
- Analyst Decision
- YGMZ
- KTTA
- Analyst Count
- YGMZ 0
- KTTA 0
- Target Price
- YGMZ N/A
- KTTA N/A
- AVG Volume (30 Days)
- YGMZ 6.5M
- KTTA 11.7M
- Earning Date
- YGMZ 01-01-0001
- KTTA 11-13-2025
- Dividend Yield
- YGMZ N/A
- KTTA N/A
- EPS Growth
- YGMZ N/A
- KTTA N/A
- EPS
- YGMZ N/A
- KTTA N/A
- Revenue
- YGMZ $31,172,395.00
- KTTA N/A
- Revenue This Year
- YGMZ N/A
- KTTA N/A
- Revenue Next Year
- YGMZ N/A
- KTTA N/A
- P/E Ratio
- YGMZ N/A
- KTTA N/A
- Revenue Growth
- YGMZ N/A
- KTTA N/A
- 52 Week Low
- YGMZ $0.11
- KTTA $0.28
- 52 Week High
- YGMZ $24.64
- KTTA $3.85
- Technical
- Relative Strength Index (RSI)
- YGMZ 37.02
- KTTA 64.25
- Support Level
- YGMZ $0.93
- KTTA $0.28
- Resistance Level
- YGMZ $1.08
- KTTA $0.75
- Average True Range (ATR)
- YGMZ 0.13
- KTTA 0.15
- MACD
- YGMZ -0.05
- KTTA 0.00
- Stochastic Oscillator
- YGMZ 1.94
- KTTA 64.17
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. The segments of the company are the trucking business, car owner services business, and liquor distribution business.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).